Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_assertion description "[In conclusion, EP administration inhibits growth and invasion of gallbladder cancer cells possibly via down-regulation of the HMGB1-RAGE axis, suggesting that EP may play a critical role in the treatment of cancer in conjunction with other therapeutic agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_assertion evidence source_evidence_literature NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_assertion SIO_000772 23298486 NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_assertion wasDerivedFrom befree-20140225 NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_assertion wasGeneratedBy ECO_0000203 NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP221301.RAQwrFwiNHx1J87JQzUuHPT0uAVGHqu9JtSI9wRAXiwMw130_provenance.